Columbia Sues Illumina Over DNA Mapping Patents

Law360, New York (March 26, 2012, 1:33 PM EDT) -- Columbia University hit Illumina Inc. with a suit in Delaware on Monday alleging the biomedical technology company's products and services used to map genes infringe five patents covering DNA sequencing technology. 

The university’s patent infringement suit comes amid Illumina's efforts to shake off drugmaker Roche Holding AG's bid to acquire the company by urging stockholders on Monday to reject Roche's $5.7 billion offer. 

In the complaint filed in Delaware federal court, Columbia claimed Illumina has produced, marketed and sold next-generation DNA sequencing products that infringed on...
To view the full article, register now.